Fujirebio receives FDA clearance for plasma test to detect Alzheimer’s-linked amyloid pathology
The test operates using the company’s fully automated Lumipulse G1200 instrument system
The test operates using the company’s fully automated Lumipulse G1200 instrument system
Roche has been recognized as No. 1 in seven of nine award categories
Roche Diagnostics, Illumina, and Siemens Healthineers among those recognized
With global colorectal cancer rates on the rise, healthcare systems need smarter ways to screen patients. FIT testing is proving to be one of the most effective and efficient tools at their disposal.
Laboratories in the Food Chemistry Division selected for elite EU working group
The comprehensive portfolio advances laboratory processes through the ability to provide earlier and more efficient detection and diagnosis
New blood test unveiled developed using artificial intelligence could lead to improved patient outcomes
Designed to support drug developers in bringing their therapeutics to market faster, more efficiently, and with greater reliability
Lateral flow test development experts share troubleshooting tips and discuss how Merck’s Hi-Flow Plus membranes can streamline assay development
Researchers identify SDR42E1 as a critical regulator of vitamin D metabolism, revealing its potential as a dual-purpose target for precision therapies
Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end
Elecsys pTau181 is the first in vitro diagnostic regulation (IVDR)-certified test to rule out Alzheimer’s associated amyloid pathology